NO965050D0 - A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin - Google Patents

A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin

Info

Publication number
NO965050D0
NO965050D0 NO965050A NO965050A NO965050D0 NO 965050 D0 NO965050 D0 NO 965050D0 NO 965050 A NO965050 A NO 965050A NO 965050 A NO965050 A NO 965050A NO 965050 D0 NO965050 D0 NO 965050D0
Authority
NO
Norway
Prior art keywords
diphenylmethyl
dioxolan
polymorphs
phenyl
propylpiperazine
Prior art date
Application number
NO965050A
Other languages
English (en)
Norwegian (no)
Other versions
NO965050L (no
Inventor
Rafael Ambros Foguet
Lluis Burniol Anglada
Jose A Hernandez Ortiz
Aurelio Munos Sacristan
Josep Maria Barenys Castello
Manuel M Raga
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO965050L publication Critical patent/NO965050L/no
Publication of NO965050D0 publication Critical patent/NO965050D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO965050A 1995-03-28 1996-11-27 A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin NO965050D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES1995/000033 WO1996030366A1 (es) 1995-03-28 1995-03-28 Polimorfos a y b de 1-(difenilmetil)-4-[3-(2-fenil-1,3-dioxolan-2-il)propil]piperazina

Publications (2)

Publication Number Publication Date
NO965050L NO965050L (no) 1996-11-27
NO965050D0 true NO965050D0 (no) 1996-11-27

Family

ID=8289110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965050A NO965050D0 (no) 1995-03-28 1996-11-27 A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin

Country Status (14)

Country Link
US (1) US5852021A (de)
EP (1) EP0785196B1 (de)
JP (1) JPH10501555A (de)
KR (1) KR970703337A (de)
AT (1) ATE194004T1 (de)
AU (1) AU690974B2 (de)
DE (1) DE69517593T2 (de)
DK (1) DK0785196T3 (de)
ES (1) ES2149353T3 (de)
FI (1) FI964653A0 (de)
GR (1) GR3034463T3 (de)
NO (1) NO965050D0 (de)
PT (1) PT785196E (de)
WO (1) WO1996030366A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES514340A0 (es) * 1982-06-17 1983-09-01 Ferrer Int "procedimiento de obtencion de nuevos derivados de piperazina".

Also Published As

Publication number Publication date
FI964653A7 (fi) 1996-11-21
US5852021A (en) 1998-12-22
DE69517593T2 (de) 2001-03-08
FI964653L (fi) 1996-11-21
ES2149353T3 (es) 2000-11-01
NO965050L (no) 1996-11-27
WO1996030366A1 (es) 1996-10-03
AU2074095A (en) 1996-10-16
ATE194004T1 (de) 2000-07-15
EP0785196A1 (de) 1997-07-23
AU690974B2 (en) 1998-05-07
DE69517593D1 (de) 2000-07-27
EP0785196B1 (de) 2000-06-21
KR970703337A (ko) 1997-07-03
JPH10501555A (ja) 1998-02-10
FI964653A0 (fi) 1996-11-21
DK0785196T3 (da) 2000-10-16
GR3034463T3 (en) 2000-12-29
PT785196E (pt) 2000-12-29

Similar Documents

Publication Publication Date Title
BR9611436A (pt) D-tartarato de (-)-cis-6(s)-fenil-5(r)-[4-(2-pirrolidin-1-iletóxi) fenil]-5,6,7,8,-tetra-hidronaftalen-2-ol
DE69602638D1 (de) Naphthylverbindungen, Zwischenprodukte, Zusammensetzungen und Methoden
DZ1961A1 (fr) Nouveaux composés.
DZ1989A1 (fr) Nouveaux composés.
NO982567D0 (no) Forbedret hydrogenolyse av 2,4,6,8,10,12-heksaazatetracyklo (5.5.0.05.903.11) dodekan
FI905535A0 (fi) Foerfarande foer reproduktion av barrtraed genom somatisk embryogenes.
DZ1798A1 (fr) Nouveaux composés.
FR2667254B1 (fr) Nebuliseur pneumatique.
MA23778A1 (fr) Purine-6-ones-2,9 disubstituees
DE69613064D1 (de) Konzentrische zweiteilige Spannzange
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
NO965050D0 (no) A- og B-polymorfene av 1-(difenylmetyl)-4- 3-(2-fenyl-1,3-dioksolan-2-yl)propyl -piperazin
FI974435A7 (fi) Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-kloorip yridiineiksi
EP0629535A3 (de) Pneumatischer Kraftverstärker.
DK1086114T3 (da) Morfin-6-glucuronidsyntese
FI964429L (fi) Menetelmä 1-(3-trialkyylisilyylifenyyli)-2,2,2-trifluorimetyylietanonin johdannaisten valmistamiseksi
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
AU549146B2 (en) 1-(1,3-benzodioxol-5-yl)-2-pyrrolidinone
NO880353D0 (no) Fremgangsmaate for fremstilling av azetidin, og nye mellomprodukter derfor.
FI914426A0 (fi) Foerfarande foer framstaellning av 1-( (2s)-3-merkaptometyl-1-oxopropyl)l-prolin.
FR2661353B1 (fr) Appareil de clouage pneumatique.
NO913713D0 (no) Gen kodende for et 30-kilodalton ytre-membranprotein av bordetella pertussis.
NL190929C (nl) 1-(Difenylmethyl)-4-(1,3-dioxolan-2-yl)-4-fenylbutylpiperazine, werkwijze voor de bereiding ervan alsmede farmaceutisch preparaat.
FI2067U1 (fi) Verktyg foer boejning av en flaens
TR199801087T2 (xx) 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application